These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Removal of linezolid by conventional intermittent hemodialysis, sustained low-efficiency dialysis, or continuous venovenous hemofiltration in patients with acute renal failure. Fiaccadori E; Maggiore U; Rotelli C; Giacosa R; Parenti E; Picetti E; Sagripanti S; Manini P; Andreoli R; Cabassi A Crit Care Med; 2004 Dec; 32(12):2437-42. PubMed ID: 15599148 [TBL] [Abstract][Full Text] [Related]
30. Effect of continuous venovenous hemofiltration with dialysis on hormone and catecholamine clearance in critically ill patients with acute renal failure. Bellomo R; McGrath B; Boyce N Crit Care Med; 1994 May; 22(5):833-7. PubMed ID: 8181293 [TBL] [Abstract][Full Text] [Related]
31. Anesthetic management in pediatric orthotopic liver transplant for fulminant hepatic failure and end-stage liver disease. Camkıran A; Araz C; Seyhan Ballı S; Torgay A; Moray G; Pirat A; Arslan G; Haberal M Exp Clin Transplant; 2014 Mar; 12 Suppl 1():106-9. PubMed ID: 24635805 [TBL] [Abstract][Full Text] [Related]
32. [Continuous venovenous hemofiltration as a bridge to heart transplantation in a patient with congestive heart failure and acute renal failure]. Brunetta B; Basić-Jukić N; Kes P Acta Med Croatica; 2003; 57(4):319-22. PubMed ID: 14639869 [TBL] [Abstract][Full Text] [Related]
33. Albumin Dialysis as a Bridge From Total Hepatectomy to Liver Transplantation for Fulminant Hepatitis With Toxic Syndrome. Levesque E; Azoulay D; Feray C; Dhonneur G Ther Apher Dial; 2016 Dec; 20(6):692-693. PubMed ID: 27629817 [No Abstract] [Full Text] [Related]
34. The pharmacokinetics and extracorporeal removal of N-acetylcysteine during renal replacement therapies. Hernandez SH; Howland M; Schiano TD; Hoffman RS Clin Toxicol (Phila); 2015; 53(10):941-9. PubMed ID: 26484583 [TBL] [Abstract][Full Text] [Related]
36. Long-term survival after 67 hours of anhepatic state due to primary liver allograft nonfunction. Arora H; Thekkekandam J; Tesche L; Sweeting R; Gerber DA; Hayashi PH; Andreoni K; Kozlowski T Liver Transpl; 2010 Dec; 16(12):1428-33. PubMed ID: 21117253 [TBL] [Abstract][Full Text] [Related]
37. Orthotopic liver transplantation with preservation of portocaval flow compared with venovenous bypass. Steib A; Saada A; Clever B; Lehmann C; Freys G; Levy S; Boudjema K Liver Transpl Surg; 1997 Sep; 3(5):518-25. PubMed ID: 9346795 [TBL] [Abstract][Full Text] [Related]
38. Beneficial impact of temporary portocaval shunt in living-donor liver transplantation with a difficult total hepatectomy. Kim JD; Choi DL Transplant Proc; 2015 Apr; 47(3):694-9. PubMed ID: 25891713 [TBL] [Abstract][Full Text] [Related]
39. Two-stage total hepatectomy and liver transplantation for acute deterioration of chronic liver disease: a new bridge to transplantation. Guirl MJ; Weinstein JS; Goldstein RM; Levy MF; Klintmalm GB Liver Transpl; 2004 Apr; 10(4):564-70. PubMed ID: 15048803 [TBL] [Abstract][Full Text] [Related]
40. Transplant Hepatectomy With Portacaval Shunt and MARS Therapy for Perioperative Catastrophe: A Series of Four Liver Transplant Cases. Cimeno A; Sultan S; Alvarez-Casas J; Hanish SI; Bruno DA; Hutson WR; Stein DM; Scalea TM; Barth RN; LaMattina JC Transplant Direct; 2021 Mar; 7(3):e674. PubMed ID: 34113714 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]